# A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Study · id `cardio:ct-nct02698852` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02698852](<https://clinicaltrials.gov/study/NCT02698852>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02698852

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT02698852. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2019-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT02698852, source copy `cardio:ctgov-nct02698852-2024-04-25`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02698852, source copy `cardio:ctgov-nct02698852-2024-04-25`, retrieved 2026-10-26)
- Primary completion: 2019-05 (actual) (ClinicalTrials.gov record NCT02698852, source copy `cardio:ctgov-nct02698852-2024-04-25`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT02698852, source copy `cardio:ctgov-nct02698852-2024-04-25`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02698852, source copy `cardio:ctgov-nct02698852-2024-04-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02698852-2024-04-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
- Acronym: OPC
- Condition: Coronary Artery Disease
- Intervention (Device): BuMA Supreme
- Lead sponsor: Sino Medical Sciences Technology Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Sino Medical Sciences Technology Inc. (`cardio:org-sino-medical-sciences-technology-inc`)

## Provenance

Content hash: a6e23397ba8332015c2eb9c7a1de833d3f45c8afdbcef9f5956b85b4fcbd1f3f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
